Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Knoll

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
International Journal for Equity in Health|August 2, 2003
Challenge of the world order and its implications for health personnelSiroos Mirzaei, Peter Knoll
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 8, 2005
Scintimammography with a pinhole collimatorSiroos Mirzaei, Peter Knoll
European Journal of Nuclear Medicine and Molecular Imaging|September 13, 2007
PET-CT is only one optionSiroos Mirzaei, Peter Knoll
Wiener Medizinische Wochenschrift (1946)|October 24, 2018
[The role of molecular imaging (PET-CT) in the diagnostic and treatment pf prostate cancer]Siroos Mirzaei, Peter Knoll, Shahin Zandieh
Wiener Klinische Wochenschrift|October 9, 2004
[Medical aspects of objectifying torture sequels]Siroos Mirzaei, Peter Knoll, Horst Köhn
Heart International|October 7, 2011
Microvascular obstruction after successful fibrinolytic therapy in acute myocardial infarction. Comparison of reteplase vs reteplase+abciximab: A cardiovascular magnetic resonance studyAntonello Zoni, Peter Knoll, Tiziano Gherli
European Journal of Nuclear Medicine and Molecular Imaging|March 27, 2007
Data acquisition and analysis: the strength of methodology in nuclear medicine and molecular imagingPeter Knoll, Horst Köhn, Siroos Mirzaei
European Journal of Nuclear Medicine and Molecular Imaging|January 16, 2008
"Wispino" protocol for 18FDG-PET scanning of myocardiumSiroos Mirzaei, Margarida Rodrigues, Peter Knoll
BMC Nuclear Medicine|March 11, 2003
Assessment of diffuse Lewy body disease by 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET)Siroos Mirzaei, Peter Knoll, Horst Koehn, et al.
Asia Oceania Journal of Nuclear Medicine & Biology|July 14, 2016
Physiologically Based Pharmacokinetic (PBPK) Model for Biodistribution of Radiolabeled Peptides in Patients with Neuroendocrine TumoursRadovan Gospavic, Peter Knoll, Siroos Mirzaei, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
International Journal for Equity in Health|August 2, 2003
Challenge of the world order and its implications for health personnelSiroos Mirzaei, Peter Knoll
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 8, 2005
Scintimammography with a pinhole collimatorSiroos Mirzaei, Peter Knoll
European Journal of Nuclear Medicine and Molecular Imaging|September 13, 2007
PET-CT is only one optionSiroos Mirzaei, Peter Knoll
Wiener Medizinische Wochenschrift (1946)|October 24, 2018
[The role of molecular imaging (PET-CT) in the diagnostic and treatment pf prostate cancer]Siroos Mirzaei, Peter Knoll, Shahin Zandieh
Wiener Klinische Wochenschrift|October 9, 2004
[Medical aspects of objectifying torture sequels]Siroos Mirzaei, Peter Knoll, Horst Köhn
Heart International|October 7, 2011
Microvascular obstruction after successful fibrinolytic therapy in acute myocardial infarction. Comparison of reteplase vs reteplase+abciximab: A cardiovascular magnetic resonance studyAntonello Zoni, Peter Knoll, Tiziano Gherli
European Journal of Nuclear Medicine and Molecular Imaging|March 27, 2007
Data acquisition and analysis: the strength of methodology in nuclear medicine and molecular imagingPeter Knoll, Horst Köhn, Siroos Mirzaei
European Journal of Nuclear Medicine and Molecular Imaging|January 16, 2008
"Wispino" protocol for 18FDG-PET scanning of myocardiumSiroos Mirzaei, Margarida Rodrigues, Peter Knoll
BMC Nuclear Medicine|March 11, 2003
Assessment of diffuse Lewy body disease by 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET)Siroos Mirzaei, Peter Knoll, Horst Koehn, et al.
Asia Oceania Journal of Nuclear Medicine & Biology|July 14, 2016
Physiologically Based Pharmacokinetic (PBPK) Model for Biodistribution of Radiolabeled Peptides in Patients with Neuroendocrine TumoursRadovan Gospavic, Peter Knoll, Siroos Mirzaei, et al.
Pageof 7